NCT06811194

Brief Summary

Abstract Background: Chronic myocardial infarction (MI) is a serious cardiovascular disease associated with high mortality rates, making early diagnosis and timely intervention essential for improving patient outcomes. However, some patients may present without clear symptoms or relevant medical histories, complicating the diagnostic process. Currently, diagnosis predominantly relies on electrocardiograms (ECGs) and imaging tests. Although cardiac magnetic resonance imaging (MRI) is regarded as the gold standard, its high cost and complexity hinder its clinical application. Consequently, there is an urgent need for new ECG diagnostic criteria to mitigate the risks of misdiagnosis and missed diagnoses. Objective: This study aims to explore new diagnostic criteria to enhance the accuracy of ECG diagnoses for chronic MI. Methods: This research is a prospective, multicenter cohort study designed to assess the impact of newly developed ECG diagnostic criteria on the accuracy of chronic myocardial infarction (MI) diagnoses. The study spans a 60-month period, including a 12-month patient enrollment phase. Participants will comprise individuals aged 35 to 85 who meet the inclusion criteria: those diagnosed with chronic myocardial infarction via ECG, those with a definitive history of MI (≥3 months), or individuals clinically suspected of having coronary artery disease with at least two coronary risk factors. Data collection will include clinical symptoms, signs, ECG findings, and cardiac magnetic resonance (CMR) findings, the latter serving as a primary endpoint. Follow-up will focus on changes in patients' symptoms and ECG assessments. Statistical analysis software will be employed to evaluate the influence of the new diagnostic criteria on rates of missed and misdiagnosis.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12,000

participants targeted

Target at P75+ for all trials

Timeline
58mo left

Started Feb 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Feb 2025Feb 2031

First Submitted

Initial submission to the registry

January 22, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 6, 2025

Completed
14 days until next milestone

Study Start

First participant enrolled

February 20, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2026

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2031

Expected
Last Updated

February 6, 2025

Status Verified

February 1, 2025

Enrollment Period

1 year

First QC Date

January 22, 2025

Last Update Submit

February 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardiovascular death or nonfatal MI.

    Primary outcome: cardiovascular death or nonfatal MI occurred during the 60-month follow-up after enrollment.

    60 Months after Enrollment

Secondary Outcomes (1)

  • A composite of cardiovascular death, nonfatal MI, hospitalization for unstable angina or congestive heart failure, and late unplanned CABG.

    60 Months after Enrollment

Study Arms (1)

Multicenter Cohort Study of Prior Myocardial Infarction

Myocardial infarction is a disease that affects the heart muscle, leading to a reduction in its function. When a patient has experienced a myocardial infarction in the past but no longer exhibits acute symptoms, it is referred to as an old myocardial infarction. This condition is typically characterized by the scarring of heart muscle tissue, resulting in partial loss of cardiac function. Patients may develop complications such as heart failure and arrhythmias. Although the symptoms may be mild, regular monitoring of cardiac function and status is essential. Early detection and management can effectively prevent further cardiovascular events. Therefore, regular medical check-ups and adherence to medical advice are crucial. For patients with a history of myocardial infarction, lifestyle modifications and pharmacological therapy are also important components in the recovery and maintenance of cardiac health.

Eligibility Criteria

Age35 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

An old MI is a condition in which the patient has experienced a myocardial infarction in the past, but no acute symptoms are present at this time. This condition usually manifests as scarring of the heart muscle tissue, resulting in a partial loss of heart muscle function. Patients may experience complications such as heart failure and arrhythmia, and although the symptoms may be mild, it is still necessary to regularly monitor the function and status of the heart. Early detection and management can effectively prevent further cardiovascular events, so regular medical check-ups and following medical advice are particularly important. For patients who have had an old heart attack, lifestyle adjustments and medication are also important components of restoring and maintaining heart health

You may qualify if:

  • Aged between 35 and 85 years.
  • Patients must meet at least one of the following conditions:
  • Diagnosis of prior MI based on ECG (as per the fourth universal definition of MI).
  • History of prior MI (≥3 months post-MI).
  • Any clinical suspicion of coronary artery disease (CAD) with at least two of the following risk factors:
  • Male age \>50 years or female age \>60 years. Diabetes mellitus. Hypertension. Hypercholesterolemia requiring medication. Family history of premature CAD (first-degree relatives: male ≤55 years, female ≤65 years).
  • Body mass index (BMI) ≥30 kg/m². History of peripheral vascular disease. History of coronary artery intervention or bypass surgery. Informed consent obtained

You may not qualify if:

  • Life expectancy \<1 year due to non-cardiovascular diseases.
  • Contraindications to cardiac MRI or inability to complete the examination.
  • History of non-ischemic cardiomyopathy.
  • History of heart transplantation.
  • Acute MI within the past 30 days.
  • During pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Third People's Hospital of Chengdu

Chengdu, Sichuan, China

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Paper records include symptoms, signs, events, and electrocardiograms (ECGs)

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 22, 2025

First Posted

February 6, 2025

Study Start

February 20, 2025

Primary Completion

February 20, 2026

Study Completion (Estimated)

February 20, 2031

Last Updated

February 6, 2025

Record last verified: 2025-02

Locations